<p class="MsoBodyText"><span lang="EN-GB">This document specifies requirements and gives recommendations on the handling, storage, CTC enrichment and isolation, DNA isolation and storage, and documentation of venous whole blood specimens intended for the examination of DNA isolated from circulating tumour cells (CTCs) during the pre-examination phase before a molecular examination is performed.</span></p>
<p class="MsoBodyText"><span lang="EN-GB">This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research, and regulatory authorities.</span></p>
<p class="MsoBodyText"><span lang="EN-GB">This document does not cover the isolation of genomic DNA directly from venous whole blood containing CTCs. This is covered in ISO 20186-2.</span></p>
<p class="MsoBodyText"><span lang="EN-GB">This document does not cover the isolation of specific white blood cells and subsequent isolation of genomic DNA therefrom or the pre-analytical workflow requirements for viable CTC cryopreservation and culturing.</span></p>
<p class="Note"><span lang="EN-GB">NOTE 1<span style="mso-tab-count: 1;"> </span>The requirements given in this document can also be applied to other circulating rare cells (e.g. foetal cells).</span></p>
<p class="Note"><span lang="EN-GB">NOTE 2<span style="mso-tab-count: 1;"> </span>International, national, or regional regulations or requirements can also apply to specific topics covered in this document.</span></p>
Registration number (WIID)
82828
Scope
<p class="MsoBodyText"><span lang="EN-GB">This document specifies requirements and gives recommendations on the handling, storage, CTC enrichment and isolation, DNA isolation and storage, and documentation of venous whole blood specimens intended for the examination of DNA isolated from circulating tumour cells (CTCs) during the pre-examination phase before a molecular examination is performed.</span></p>
<p class="MsoBodyText"><span lang="EN-GB">This document is applicable to molecular in vitro diagnostic examinations including laboratory developed tests performed by medical laboratories. It is also intended to be used by laboratory customers, in vitro diagnostics developers and manufacturers, biobanks, institutions, and commercial organizations performing biomedical research, and regulatory authorities.</span></p>
<p class="MsoBodyText"><span lang="EN-GB">This document does not cover the isolation of genomic DNA directly from venous whole blood containing CTCs. This is covered in ISO 20186-2.</span></p>
<p class="MsoBodyText"><span lang="EN-GB">This document does not cover the isolation of specific white blood cells and subsequent isolation of genomic DNA therefrom or the pre-analytical workflow requirements for viable CTC cryopreservation and culturing.</span></p>
<p class="Note"><span lang="EN-GB">NOTE 1<span style="mso-tab-count: 1;"> </span>The requirements given in this document can also be applied to other circulating rare cells (e.g. foetal cells).</span></p>
<p class="Note"><span lang="EN-GB">NOTE 2<span style="mso-tab-count: 1;"> </span>International, national, or regional regulations or requirements can also apply to specific topics covered in this document.</span></p>
